Pursuant to Regulation 30 of the Listing Regulations, Dr. Lal PathLabs has informed that it enclosed the Press Release titled ‘Dr. Lal PathLabs Becomes South Asia’s First Diagnostic Chain to Launch Advanced Test for Amyloidosis’.
The above information is a part of company’s filings submitted to BSE.